Enliven Therapeutics, Inc.

ELVN·NASDAQ·$42.53Share Price as of 11/2·$3BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/05/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202503/03/26 10-QQ3 ended 09/30/2511/12/25 10-QQ2 ended 06/30/2508/13/25

Disclosures

8-KCurrent report10/14/26 8-KResults of Operations08/05/26 8-KEntry into Material Agreement; Regulation FD Disclosure06/12/26 8-KRegulation FD Disclosure; Other Events06/11/26 8-KAmendments to Articles or Bylaws; Shareholder Vote Results06/10/26

Prospectuses and Registrations

424B5Prospectus supplement06/12/26 424B5Prospectus supplement06/11/26 S-8Registration of securities for employees03/03/26 S-8Registration of securities for employees12/16/25 S-3ASRAutomatic shelf registration08/13/25

Proxies

DEF 14ADefinitive proxy04/27/26 DEFA14AAdditional proxy materials04/27/26 PRE 14APreliminary proxy04/15/26 DEF 14ADefinitive proxy04/28/25 DEFA14AAdditional proxy materials04/28/25

Ownership

Form 4Insider transaction10/21/26 Form 4Insider transaction10/21/26 144Proposed sale of securities10/19/26 Form 3Initial insider ownership10/16/26 Form 4Insider transaction10/16/26

Other

ARSAnnual report to shareholders04/27/26 ARSAnnual report to shareholders04/28/25 EFFECTRequest for effectiveness04/30/24 ARSAnnual report to shareholders04/26/24 CORRESPCorrespondence with the SEC04/26/24